Real-time enrollment status for this type 2 diabetes mellitus clinical trial
Current Status
Recruiting
Checked: July 15, 2026 at 6:31 PM UTC
| NCT Number | NCT07662213 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes Mellitus |
| Phase | PHASE3 |
| Target Enrollment | 1,200 participants |
| Active Locations | 63 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 14, 2026 (Yesterday) |
As of July 15, 2026: Clinical trial NCT07662213 is currently recruiting participants. This phase3 study for type 2 diabetes mellitus is actively seeking new participants at 63 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07662213 is actively recruiting participants as of July 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07662213 was last updated Yesterday (July 14, 2026). HelloStudys verifies this status automatically.